11.14.25 -- Pfizer's Accord For A Healthier World Program Challenges Stability Study Norms

Explore the differences between liquid nitrogen and mechanical cryogenic freezers, and learn how each method supports scientific, medical, and industrial storage needs.

Uneven ice formation during bottle freezing creates a "Volcano Effect," pushing solutes into highly concentrated zones. This test-based study explains this risk to drug substance quality.

While barrier films in bags can be useful for cold chain applications, they do not fully protect against gas ingress and ignore other sources of permeability.

Minimizing liquid dead volume helps labs conserve costly reagents and scarce samples while boosting assay throughput. Learn how advanced liquid level detection technologies are driving efficiency.

Effectively managing process parameters and quality attributes is vital for successful drug development. Learn how a Quality by Design approach can optimize your processes and ensure product quality.

Discover how one family's race against time led to the creation of a groundbreaking gene therapy for their daughter, just 14 months after her ultra-rare disease diagnosis.

Understand how turbulent-jet mixing ensures predictable and reproducible nanoparticle size and uniformity across all scales, accelerating development and regulatory readiness.

Explore the pivotal advancements in ADCs that focus on high-DAR, multispecific designs, and novel payloads, while addressing challenges in manufacturability, scalability, regulatory acceptance, and more.

Learn about how meticulous purification optimization can maximize recovery and impurity removal by leveraging scalable downstream technologies to meet regulatory and process economy requirements.

By leveraging transposase-mediated technologies together with transposon design to achieve semi-targeted integration, drug developers can more efficient and consistent biotherapeutic protein production.

Embrace the future of drug development by leveraging AI and innovative protein synthesis technologies to accelerate the creation of effective therapies and transform patient outcomes.

Explore how Life Sciences teams are aligning digital innovation with patient outcomes through connected systems, scalable data strategies, and collaborative development.

Biotherapeutic peptides offer enhanced safety and efficacy over traditional drugs. Learn why rigorous impurity profiling is vital to ensure product quality, patient safety, and regulatory compliance.

Tube welding and biosafety cabinets present significant costs and risks for small-volume aseptic processing. Modern single-use aseptic connectors offer a more efficient alternative.

Scaling up stem cell production presents unique hurdles. Discover crucial considerations, from initial development to large-scale manufacturing, to ensure cell quality and successful outcomes.

Transitioning from manual to automated cell processing is key to therapeutic success. This versatile single-use system can simplify operations and reduce variability throughout manufacturing.

Digital PCR enables fast, sensitive mycoplasma detection in cell-based products. Learn how this workflow improves accuracy, reduces delays, and supports reliable decision-making.

Review studies that showcase the potential of the CHOgro Expression System in early stage drug development, where high titer antibody production in suspension CHO cells is crucial.